ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
ESC Premium Access
Cardiovascular disease prevention with antihyperglycaemic and cholesterol lowering therapy in type 2 diabetes
Event:
ESC CONGRESS 2017
Topic:
Diabetes, dysglycaemia and metabolic syndrome
Session type:
Advances in Science
Date:
28 August 2017
Time:
14:00 - 15:30
Session
0
5
presentations
in this session
State of the Art: cardiovascular disease prevention with antihyperglycaemic and cholesterol lowering therapy in type 2 diabetes
Speaker:
Professor D. De Zeeuw (Groningen, NL)
Access
Slides
Video
0
Risk of major cardiovascular events in patients with type 2 diabetes with and without prior cardiovascular events: results from the LEADER trial
Speaker:
Professor N. Poulter (London, GB)
Access
Abstract
Slides
Video
0
SUSTAIN 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes
Speaker:
Doctor E. Jodar Gimeno (Pozuelo de Alarcon, ES)
Access
Abstract
Slides
Video
0
Impact of CETP inhibition with evacetrapib in patients with diabetes mellitus: results from ACCELERATE
Speaker:
Doctor V. Menon (Cleveland, US)
Access
Abstract
Slides
Video
0
Cardiovascular outcome trials in type 2 diabetes: lessons learned and questions to ask.
Speaker:
Professor L. Ryden (Stockholm, SE)
Access
Slides
Video
0
5
speakers
from this session
Professor Dick De Zeeuw
, Groningen (Netherlands (The))
1
presentation
0
follower
Professor Neil Poulter
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
21
presentations
0
follower
Doctor Esteban Jodar Gimeno
Universitary Hospital Quironsalud Madrid, Pozuelo de Alarcon (Spain)
0
follower
Doctor Venu Menon
Cleveland Clinic Foundation, Cleveland (United States of America)
7
presentations
0
follower
Professor Lars Ryden
Department of medicine, Karolinska Institutet, Stockholm, Stockholm (Sweden)
31
presentations
0
follower
This platform is supported by